Traduction de «effect of carvedilol in patients with severe » (Néerlandais → Français) :

16. Rouleau J, Roecker E, Tendera M et al. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.
systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.

Aclasta is approved for up to six indications worldwide, treating a broad spectrum of patients from those with early bone loss to patients with more severe forms of this metabolic bone disease.
Reclast/Aclast est autorisé pour jusqu’à six indications dans le monde entier, traitant les différents degrés de cette maladie métabolique allant des pertes osseuses précoces aux formes plus sévères.

Approved in up to six indications worldwide, Reclast/Aclasta provides fracture protection to a broad spectrum of patients ranging from those diagnosed with early bone loss to patients with more severe forms of the disease and has been used in more than one million infusions.
Autorisé pour jusqu’à six indications dans le monde entier, Aclasta/Reclast protège contre les fractures sur toute l’étendue de la maladie allant de la perte osseuse précoce aux formes plus sévères.

Incremental benefits have been observed with indacaterol in escalating doses from 75 mcg up to 300 mcg, with higher doses showing increasing benefit for patients, particularly those with more severe disease.
Une augmentation du dosage de 75 mcg à 300 mcg s’est traduite par une progression des bénéfices pour les malades, les doses plus élevées profitant plus à ces derniers, en particulier, à ceux qui souffrent des formes plus sévères de la maladie.

Novartis has several other drugs in its pipeline that have promise for patients with unmet needs.
Novartis possède plusieurs autres médicaments dans son pipeline qui répondent aux besoins non satisfaits des malades.

Kaltenbach T, Crockett S, Gerson L. Are lifestyle measures effective in patients with gastroesophagal reflux disease?
Search Date July 2007. [http ...]

Wandel S, Jüni P, Tendal B et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis.
Gabay C, Medinger-Sadowski C, Gascon D et al. Symptomatic effects of chondroitin 4 and Chondroitin 6 sulfate on hand osteoarthritis.

Patel A, MacMahon S, Chalmers J et al. Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes mellitus: results of the ADVANCE trial.
Folia Pharmacotherapeutica 2011; 38:62. [http ...]

Bespreking van: van Walraven C, Hart RG, Conolly S et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the Atrial Fibrillation Investigators.
Dunn A. Oral anticoagulant therapy safely prevented stroke in older patients with atrial fibrilllation. Evid Based Med 2009; 14:140.

Delivering innovation, growth and productivity Novartis continues to advance its strategy to meet the needs of patients everywhere with a broad healthcare portfolio that includes innovative medicines, preventive vaccines, cost-effective generics and self-care products.
Promouvoir l'innovation, la croissance et la productivité Novartis continue de développer sa stratégie pour répondre aux besoins des malades où qu’ils soient avec un vaste portefeuille de soins de santé qui comprend des médicaments innovants, des vaccins préventifs, des génériques peu coûteux et des produits d’automédication.